A comprehensive view of Takeda Pharmaceutical Co. Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Kao Industrial, Takeda sign Thailand Dengue Prevention and Control memorandum of understanding; collaboration aims to cover all 50 districts in Bangkok and extend to other provinces nationwide to raise awareness about Dengue fever, increase prevention

MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda drugs to treat attention-deficit/hyperactivity disorder

Puma Biotechnology to license Japanese drug firm Takeda’s experimental oral drug alisertib used to treat breast and lung cancers in deal worth up to US$294.0M; Puma to be responsible for global development, commercialization of the drug

Takeda’s injectable Takhzyro lanadelumab-flyo now available in US in single-dose prefilled syringes to prevent attacks of hereditary angioedema in adult, pediatric patients 12 years of age and older; HAE affects 1 in 50,000 people worldwide

Takeda announces approval in Japan for TAKHZYRO subcutaneous injection for prevention of acute attacks of hereditary angioedema; condition is a rare genetic disorder that causes recurring swelling

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count